Utility of SUVmax on Primary Staging 68Ga-PSMA PET/CT in Determining Metastatic Status of Prostate Cancer

Geoffrey Liu1,2, Shane Lee1,2, Kabir Ahmad1,2

  • 1Barwon Medical Imaging, Barwon Health, Geelong, Australia.

Abstract

Insights

The maximum standardized uptake value (SUVmax) of primary prostate lesions shows a weak but significant link to metastasis detection using 68Ga-PSMA PET/CT. However, SUVmax alone is unreliable for predicting advanced prostate cancer due to significant overlap.

Area of Science:

  • Nuclear Medicine
  • Oncology
  • Radiology

Background:

  • 68Ga-PSMA PET/CT is valuable for detecting prostate cancer metastasis.
  • Equivocal uptake in suspected metastases can occur, necessitating further prognostic indicators.
  • The prognostic value of SUVmax in primary prostate lesions requires further investigation.

Purpose of the Study:

  • To investigate the direct relationship between the SUVmax of primary prostate lesions and the presence of nodal and distant metastases.
  • To determine if SUVmax can serve as a predictor for advanced prostate cancer staging.

Main Methods:

  • Retrospective review of 265 primary staging 68Ga-PSMA PET/CT studies.
  • Analysis of SUVmax of the primary prostate lesion.
  • Assessment of the presence of PSMA-avid nodal and distant metastases.

Main Results:

  • A single unit increase in primary lesion SUVmax correlated with a 1.6% increased odds of nodal metastases and 1.7% for distant metastases.
  • Increased SUVmax of the primary lesion showed a 2% increased odds of any metastasis.
  • Log SUVmax increases corresponded to odds ratios between 2.038 and 2.294 for metastasis.

Conclusions:

  • A statistically significant, albeit weak, correlation exists between primary prostate SUVmax and metastasis detection on 68Ga-PSMA PET/CT.
  • Significant overlap in SUVmax values between local and advanced disease limits its predictive capability.
  • SUVmax of the primary lesion is unreliable as the sole predictor of advanced prostate cancer.